The Department of Science and Technology-funded research and development study on lagundi as a supplementary treatment against Covid19 had begun last September right after the Food and Drug Administration gave it the green light.
P4.9 million has been allocated for the clinical trials.
According to secretary Fortunato dela Peña, 75 mild or suspected Covid patients have been entered at the Quezon Institute and the Philippine National Police-National Capital Region Police Office (PNP-NCRPO) quarantine facilities. As of October 30, 59 patients have finished the regimen.
The targeted number of participants for the clinical trials is 280.
R&D studies will also be conducted on the tawa-tawa plant. Other potential cures for the disease that have been explored are melatonin, convalescent plasma and virgin coconut oil (VCO).
P5 million is set aside for each of two new R&D projects on VCO. These will be done by the Food and Nutrition Research Institute and DOST-CALABARZON, Santa Rosa, Laguna local government, the Philippine Coconut Authority, the University of the Philippines General Hospital and the UP-National Institutes of Health.